InsidersTradesSigma
Follow the 联环药业 stock price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 联环药业 has published 1 insider filings. Market capitalisation: €4.4bn. The latest transaction was disclosed on 8 November 2024 (Purchase). Among the most active insiders: 王春元. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
联环药业 es una empresa del sector de la salud y farmacéutico, que cotiza en la Bolsa de Shanghái. Se enfoca en la investigación, desarrollo y producción de medicamentos y productos farmacéuticos.